SCHEMBL30103024

SCHEMBL30103024

COCc1cn(-c2ccn3ncc(-c4cccnc4OC)c3n2)cn1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AAK1 Q2M2I8 1/20 0.52
▸ FYN P06241 3/20 0.39
▸ JAK2 O60674 4/20 0.36
▸ JAK3 P52333 4/20 0.36
▸ PTK2 Q05397 4/20 0.36
▸ PSEN1 P49768 1/20 0.35
▸ PSEN2 P49810 1/20 0.35
▸ APH1B Q8WW43 1/20 0.35
▸ NCSTN Q92542 1/20 0.35
▸ APH1A Q96BI3 1/20 0.35
▸ PSENEN Q9NZ42 1/20 0.35
▸ NTRK1 P04629 1/20 0.34
▸ TGFBR2 P37173 2/20 0.33
▸ KDR P35968 2/20 0.33
▸ ACVR2A P27037 1/20 0.33
▸ TGFBR1 P36897 1/20 0.33
▸ BMPR1B O00238 1/20 0.33
▸ BMP4 P12644 1/20 0.33
▸ BMPR1A P36894 1/20 0.33
▸ ACVRL1 P37023 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23931665 0.90 AAK1 (0.54) AAK1FYNJAK2JAK3PTK2
SCHEMBL30102937 0.90 AAK1 (0.54) AAK1FYNJAK2JAK3PTK2
SCHEMBL20081018 0.75 AAK1 (0.50) AAK1FYNJAK2JAK3PTK2
SCHEMBL17495348 0.74 AAK1 (0.67) AAK1JAK2JAK3PTK2TGFBR2
SCHEMBL29398488 0.74 AAK1 (0.67) AAK1JAK2JAK3PTK2TGFBR2
SCHEMBL20081012 0.72 AAK1 (0.69) AAK1FYNJAK2JAK3PTK2
SCHEMBL30172473 0.72 AAK1 (0.59) AAK1FYNJAK2JAK3PTK2
Hydrochloric Acid SCHEMBL30172429 0.72 BMP4 (0.50) AAK1JAK2JAK3PTK2PSEN1
SCHEMBL20081020 0.71 AAK1 (0.80) AAK1JAK2JAK3PTK2PSEN1
SCHEMBL19467027 0.71 AAK1 (0.83) AAK1JAK2JAK3PTK2PSEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115427045-A 4- (3- (pyridin-3-yl) pyrazolo [1,5-a ] pyrimidin-5-yl) piperazine for the treatment of COV-229E or COV-OC43 coronavirus infection 莱西肯医药有限公司 2022-12-02 — — CN disclosed
Send feedback